Back
ESC Premium Access

High H2FPEF score is an independent predictor of adverse outcome in patients with severe aortic stenosis and preserved ejection fraction undergoing TAVR

Session: TAVR outcomes: the future is here
Topic: Aortic Valve Intervention
Speaker: Doctor S. Ludwig (Hamburg, DE)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Sebastian Ludwig

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
2 presentations
0 follower

5 more presentations in this session

Mortality of surgical redo aortic valve replacement versus transcatheter aortic valve-in-valve implantation in patients with degenerated aortic bioprosthesis: a meta-analysis.

Speaker: Doctor A. Pardo Sanz (Madrid, ES)

Access
Abstract
Slides
Thumbnail

Incidence, risk factors and impact of readmission for heart failure after successful transcatheter aortic valve replacement

Speaker: Doctor P. Guedeney (Paris, FR)

Access
Abstract
Slides
Thumbnail

Timing and associated predictors of onset of new conduction disturbances requiring permanent pacemaker implantation after transcatheter aortic valve implantation

Speaker: Miss N. Kooistra (Utrecht, NL)

Access
Abstract
Thumbnail

Validation of the cardiac damage classification and additional effects of albumin levels in a large cohort of patients undergoing transcatheter aortic valve replacement

Speaker: Doctor A. Berkovitch (Ramat Gan, IL)

Access
Abstract
Slides
Thumbnail

Stroke after transcatheter aortic valve implantation: an unpredictable risk?

Speaker: Mr G. Bosbach (Duesseldorf, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

TAVR outcomes: the future is here

Speakers: Doctor S. Ludwig, Doctor A. Pardo Sanz, Doctor P. Guedeney, Miss N. Kooistra, Doctor A. Berkovitch...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb